Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18673607

Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass

Author
RECKER, Robert R1 ; KENDLER, David2 ; GAICH, Carol L8 ; WONG, Mayme8 ; PLOUFFE, Leo8 ; STOCK, John L8 ; RECKNOR, Christopher P3 ; ROONEY, Theodore W4 ; LEWIECKI, E. Michael5 ; UTIAN, Wulf H6 ; CAULEY, Jane A7 ; LORRAINE, Joanne8 ; YONGMING QU8 ; KULKAMI, Pandurang M8
[1] Creighton University, Osteoporosis Research Center, 601 North 30th Street, Suite 5766, Omaha, NE 68131, United States
[2] Osteoporosis Research Centre, Vancouver, BC, Canada
[3] United Osteoporosis Centers, Gainesville, GA, United States
[4] Mercy Arthritis and Osteoporosis Center, Des Moines, IA, United States
[5] New Mexico Clinical Research and Osteoporosis Center, Albuquerque, NM, United States
[6] Rapid Medical Research, Cleveland, OH, United States
[7] University of Pittsburgh, Pittsburgh, PA, United States
[8] Eli Lilly and Company, Indianapolis, IN, United States
Source

Bone (New York, NY). 2007, Vol 40, Num 4, pp 843-851, 9 p ; ref : 38 ref

ISSN
8756-3282
Scientific domain
Orthopedics traumatology; Physiology, morphology
Publisher
Elsevier Science, New York, NY
Publication country
United States
Document type
Article
Language
English
Author keyword
Alendronate Fracture Osteoporosis Postmenopausal Raloxifene
Keyword (fr)
Acide alendronique Anticancéreux Etude comparative Femme Fracture Masse osseuse Ostéoporose Postménopause Pronostic Raloxifène Antiostéoclastique Antiostéoporotique Modulateur sélectif récepteur oestrogène Agoniste antagoniste Antihormone Antioestrogène Benzothiophène dérivé Bisphosphonates Composé non stéroïde Diphosphonique acide dérivé Homme Récepteur oestrogène Système ostéoarticulaire pathologie Traumatisme
Keyword (en)
Alendronic acid Antineoplastic agent Comparative study Woman Fracture Bone mass Osteoporosis Postmenopause Prognosis Raloxifene Agonist antagonist Antihormone Antiestrogen Benzothiophene derivatives Bisphosphonates Non steroid compound Diphosphonic acid derivatives Human Estrogen receptor Diseases of the osteoarticular system Trauma
Keyword (es)
Acido alendrónico Anticanceroso Estudio comparativo Mujer Fractura Masa oseosa Osteoporosis Postmenopausia Pronóstico Raloxifeno Agonista antagonista Antihormona Antiestrógeno Benzotiofeno derivado Bisfosfonatos Compuesto no esteroide Difosfonico ácido derivado Hombre Receptor estrógeno Sistema osteoarticular patología Traumatismo
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02L Bones, joints and connective tissue. Antiinflammatory agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B15 Diseases of the osteoarticular system / 002B15A Osteoporosis. Osteomalacia. Paget disease

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B16 Traumas. Diseases due to physical agents / 002B16H Injuries of the limb. Injuries of the spine

Discipline
Osteoarticular pathology Pharmacological treatments Traumas. Diseases caused by physical agents
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
18673607

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web